Gyon Technologies Capital Management’s Puma Biotechnology PBYI Stock Holding History

Gyon Technologies Capital Management’s Portfolio PBYI Stock Details PBYI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-11,464	Closed	-$80K	–	626
2021 Q3	$80K	Buy	+11,464	New	+$85.8K	0.02%	361
2021 Q1	–	Sell	-14,054	Closed	-$144K	–	481
2020 Q4	$144K	Buy	+14,054	New	+$142K	0.05%	330
2020 Q3	–	Sell	-29,745	Closed	-$310K	–	297
2020 Q2	$310K	Buy	+29,745	New	+$308K	0.75%	49

Other funds holding PBYI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Gyon Technologies Capital Management's PBYI Position: Q4 2021 in Review

Gyon Technologies Capital Management sold out of Puma Biotechnology (PBYI) in Q4 2021, closing a stake of 11,464 shares — an estimated $80K sold.

Gyon Technologies Capital Management first reported a position in PBYI in Q2 2020 and held it in 3 quarters. The position peaked at $310K in Q2 2020. 102 funds tracked by Wall St. Rank hold PBYI as of Q4 2021.

Gyon Technologies Capital Management reported no remaining Puma Biotechnology position as of Q4 2021 after selling out during the quarter.
Gyon Technologies Capital Management sold 11,464 Puma Biotechnology shares in Q4 2021, an estimated $80K.
Gyon Technologies Capital Management first reported a position in Puma Biotechnology in Q2 2020 and held it in 3 quarters.
Gyon Technologies Capital Management's Puma Biotechnology position peaked at $310K in Q2 2020.
102 funds tracked by Wall St. Rank held Puma Biotechnology as of Q4 2021.

Based on Gyon Technologies Capital Management's 13F filing for Q4 2021, filed 11 Feb 2022.